55I LLC’s ENDRA Life Sciences NDRA Stock Holding History

55I LLC’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	-$35K	–	636
2022 Q1	$35K	Hold	3	–	–	﹤0.01%	509
2021 Q4	$61K	Hold	3	–	–	﹤0.01%	481
2021 Q3	$154K	Hold	3	–	–	﹤0.01%	470
2021 Q2	$194K	Hold	3	–	–	0.01%	388
2021 Q1	$231K	Buy	+3	New	+$225K	0.01%	282

Other funds holding NDRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

55I LLC's NDRA Position: Q2 2022 in Review

55I LLC sold out of ENDRA Life Sciences (NDRA) in Q2 2022, closing a stake of 3 shares — an estimated $35K sold.

55I LLC first reported a position in NDRA in Q1 2021 and held it in 5 quarters. The position peaked at $231K in Q1 2021. 13 funds tracked by Wall St. Rank hold NDRA as of Q2 2022.

55I LLC reported no remaining ENDRA Life Sciences position as of Q2 2022 after selling out during the quarter.
55I LLC sold 3 ENDRA Life Sciences shares in Q2 2022, an estimated $35K.
55I LLC first reported a position in ENDRA Life Sciences in Q1 2021 and held it in 5 quarters.
55I LLC's ENDRA Life Sciences position peaked at $231K in Q1 2021.
13 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2022.

Based on 55I LLC's 13F filing for Q2 2022, filed 12 Aug 2022.